Abstract
DOPAMINE receptors are the principal targets of drugs used in the treatment of schizophrenia1. Among the five mammalian dopamine-receptor subtypes, the D4 subtype is of particular interest because of its high affinity for the atypical neuroleptic clozapine1–3. Interest in clozapine stems from its effectiveness in reducing positive and negative symptoms in acutely psychotic and treatment-resistant schizophrenic patients without eliciting extrapyramidal side effects4. We have produced a subtype-specific antibody against the D4 receptor and localized it within specific cellular elements and synaptic circuits of the central nervous system. The D4-receptor antibody labelled GABAergic neurons in the cerebral cortex, hippocampus, thalamic reticular nucleus, globus pallidus and the substantia nigra (pars reticulata). Labelling was also observed in a subset of cortical pyramidal cells. Our findings suggest that clozapine's beneficial effects in schizophrenia may be achieved, in part, through D4-mediated GABA modulation, possibly implicating disinhibition of excitatory transmission in intrinsic cortical, thalamocortical and extrapyramidal pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Seeman, P. & Van Tol, H. H. M. Trends pharmac. Sci. 15, 264–270 (1994).
Van Tol, H. H. M. et al. Nature 350, 614–619 (1991).
Meltzer, H. Y. J. clin. Psychiat. 55, 47–52 (1994).
Lee, M. A., Thompson, P. A. & Meltzer, H. Y. J. clin. Psychiat. 55, 82–87 (1994).
Mansour, A. et al. Soc. Neumsci. Abstr. 17, 599 (1991).
Bergson, C. et al. J. Neurosci. 15, 7821–7837 (1995).
Levey, A. I. et al. Proc. natn. Acad. Sci. U.S.A. 90, 8861–8865 (1993).
Houser, C. R., Vaughn, J. E., Hendry, S. H. C., Jones, E. G. & Peters, A. in Cerebral Cortex Vol. 2 (eds Jones, E. G. & Peters, A.) 63–89 (Plenum, New York and London, 1984).
Celio, M. R. Neuroscience 35, 375–475 (1990).
Siegel, S. J. et al. J. Neurosci. 15, 2707–2719 (1995).
Houser, C. R., Vaughn, J. E., Barber, R. P. & Roberts, E. Brain Res. 200, 341–354 (1980).
Steriade, M., McCormick, D. A. & Sejnowski, T. J. Science 262, 679–685 (1993).
Liu, X.-B., Warren, R. A. & Jones, E. G. J. comp. Neurol. 352, 187–202 (1995).
Elomaa, E. Med. Hypoth. 43, 245–246 (1994).
Mugnaini, E. & Oertel, W. H. in Handbook of Chemical Neuroanatomy Vol. 4 (eds Bjorklund, A. & Hokfelt, T.) 436–608 (Elsevier, Amsterdam, 1985).
Delfs, J. M., Anegawa, N. J. & Chesselet, M. F. Neuroscience 66, 67–80 (1995).
DeLong, M. R. & Wichmann, T. clin. Neurosci. 1, 18–26 (1993).
Bunney, B. S. & Agajanian, G. K. Life Sci. 19, 1783–1792 (1976).
Martin, K. A. C. Q. J. exp. Physiol. 73, 637–702 (1988).
Ferron, A., Thierry, A. M., Le Douarin, C. & Glowinski, J. Brain Res. 302, 257–265 (1984).
Gellman, R. L. & Aghajanian, G. K. Brain Res. 600, 63–73 (1993).
Bourdelais, A. J. & Deutsch, A. Y. Cereb. Cortex 4, 69–77 (1994).
Retaux, S., Besson, M. J. & Penit-Soria, J. Neuroscience 42, 61–71 (1991).
Kim, J. S., Kornhuber, H. H., Schmid-Burgh, W. Holtzmuller, B. Neurosci. Lett. 20, 379–382 (1980).
Weinberger, D. R., Berman, K. F. & Zec, R. F. Arch. gen. Psychiat. 43, 114–124 (1986).
DeFelipe, J., Hendry, S. H. C., Hashikawa, T. & Jones, E. G. Cereb. Cortex 1, 117–133 (1991).
Gellman, R. L. & Aghajanian, G. K. Neuroscience 58, 515–525 (1994).
Chio, C. L. et al. J. biol. Chem. 269, 11813–11819 (1994).
Huttner, W. B., Schiebler, W., Greengard, P. & De Camilli, P. J. Cell Biol. 96, 1374–1388 (1983).
Dunkley, P. R., Jarvie, P. E., Heath, J. W., Kidd, J. G. & Rostas, J. A. P. Brain Res. 372, 115–129 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mrzljak, L., Bergson, C., Pappy, M. et al. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381, 245–248 (1996). https://doi.org/10.1038/381245a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/381245a0
This article is cited by
-
Adaptive control of synaptic plasticity integrates micro- and macroscopic network function
Neuropsychopharmacology (2023)
-
Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine
Neuropsychopharmacology (2022)
-
Disordered eating in early childhood: DRD4 and DAT1 gene polymorphisms and quality of mother–child interaction
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2022)
-
Bidirectional modulation of hippocampal synaptic plasticity by Dopaminergic D4-receptors in the CA1 area of hippocampus
Scientific Reports (2017)
-
Using a novel PV-Cre rat model to characterize pallidonigral cells and their terminations
Brain Structure and Function (2017)